SANOFICONR — Sanofi Consumer Healthcare India Share Price
- IN₹113.87bn
- IN₹110.76bn
- IN₹7.25bn
- 86
- 10
- 83
- 66
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 41.67 | ||
Price to Tang. Book | 41.96 | ||
Price to Free Cashflow | 26.51 | ||
Price to Sales | 15.7 | ||
EV to EBITDA | 45.68 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 79.05% | ||
Return on Equity | 75.32% | ||
Operating Margin | 32.81% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | IN₹m | n/a | n/a | n/a | 5,554 | 7,245 | n/a | n/a | 30.45% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | +21.4 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Sanofi Consumer Healthcare India Limited is an India-based company. It is engaged in the business of manufacturing, producing, processing, marketing, formulating, buying, trading, storing, packing, selling, distributing, importing, exporting, providing consultancy and otherwise dealing in all kinds of varieties of pharmaceuticals, especially consumer healthcare products, including: basic drugs; drug intermediates; chemical, medical, biological and electrolytic drugs, ingredients, Medicare, preparations and compositions; medicines, preparations and formulations in all or any forms, including formulations in which various drugs are processed; patents, medicines, drugs enzymes, fermentations and generic products, vitamin and vitamins products tonic, food products, nutritional products, products in therapies such as pain care, allergy, digestive health, cough & cold, sleep, general wellness and hormones and hormone products, and ingredients of every kind and other articles, and compounds.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- May 10th, 2023
- Public Since
- September 13th, 2024
- No. of Shareholders
- 57,338
- No. of Employees
- 583
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
National Stock Exchange of India
- Shares in Issue
- 23,030,622

- Address
- 3Rd Floor, Sanofi House, MUMBAI, 400072
- Web
- Phone
- +91 2228032000
- Auditors
- Kalyaniwalla & Mistry Chartered Accountants
Upcoming Events for SANOFICONR
Sanofi Consumer Healthcare India Ltd Annual Shareholders Meeting
Similar to SANOFICONR
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
As of Today at 23:04 UTC, shares in Sanofi Consumer Healthcare India are trading at IN₹4,939.00. This share price information is delayed by 15 minutes.
Shares in Sanofi Consumer Healthcare India last closed at IN₹4,939.00 and the price had moved by over the past 365 days. In terms of relative price strength the Sanofi Consumer Healthcare India share price has matched the S&P BSE 100 Index by over the past year.
There is no consensus recommendation for this security.
Find out moreThe Sanofi Consumer Healthcare India dividend yield is 1.11% based on the trailing twelve month period.
Last year, Sanofi Consumer Healthcare India paid a total dividend of IN₹55.00, and it currently has a trailing dividend yield of 1.11%.Looking ahead, the next dividend pay date is 2025-05-20.
We do not have data on when Sanofi Consumer Healthcare India is to next pay dividends. The historic dividend yield on Sanofi Consumer Healthcare India shares is currently 1.11%.
To buy shares in Sanofi Consumer Healthcare India you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹4,939.00, shares in Sanofi Consumer Healthcare India had a market capitalisation of IN₹113.87bn.
Here are the trading details for Sanofi Consumer Healthcare India:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: SANOFICONR
Based on an overall assessment of its quality, value and momentum Sanofi Consumer Healthcare India is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sanofi Consumer Healthcare India. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +6.17%.
As of the last closing price of IN₹4,939.00, shares in Sanofi Consumer Healthcare India were trading +1.92% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Sanofi Consumer Healthcare India PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹4,939.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Sanofi Consumer Healthcare India's directors